IGF‐1 TMJ injections enhance mandibular growth and bone quality in juvenile rats
- 9 August 2021
- journal article
- research article
- Published by Wiley in Orthodontics & Craniofacial Research
- Vol. 25 (2) , 183-191
Abstract
Objectives Dentofacial orthopaedic treatment of mandibular hypoplasia has unpredictable skeletal outcomes. Although several biomodulators including insulin-like growth factor 1 (IGF-1) are known to contribute to chondrocyte proliferation, their efficacy in modulating mandibular growth has not been validated. The aim of this study was to determine the effect of locally delivered IGF-1 on mandibular growth and condylar bone quality/quantity in juvenile rats. Setting and sample population Institutional vivarium using twenty-four 35-day-old male Sprague-Dawley rats. Methods PBS or 40 µg/kg (low-dose) IGF-1 or 80 µg/kg (high-dose) IGF-1 was injected bilaterally into the temporomandibular joints of the rats at weekly intervals for four weeks. Cephalometric and micro-computed tomography measurements were used to determine mandibular dimensions. Bone and tissue mineral density, volume fraction and mineral content were determined, and serum IGF-1 concentrations assayed. Results Intra-articular administration of high-dose IGF-1 contributed to a significant 6%-12% increase in mandibular body and condylar length compared to control and low-dose IGF-1-treated animals. Additionally, IGF-1 treatment resulted in a significant decrease in the angulation of the lower incisors to mandibular plane. Condylar bone volume, bone volume fraction, mineral content and mineral density were significantly increased with high-dose IGF-1 relative to control and low-dose IGF-1 groups. Serum IGF-1 levels were similar between all groups confirming limited systemic exposure to the locally administered IGF-1. Conclusion Local administration of high-dose 80 µg/kg IGF-1 enhances mandibular growth and condylar bone quality and quantity in growing rats. The findings have implications for modulating mandibular growth and potentially enhancing condylar bone health and integrity.Keywords
Funding Information
- National Institutes of Health (R01 DE018455)
This publication has 40 references indexed in Scilit:
- Craniofacial MicrosomiaSeminars in Plastic Surgery, 2012
- IGF-1 and bone: New discoveries from mouse modelsJournal of Bone and Mineral Research, 2010
- Update in New Anabolic Therapies for OsteoporosisThe Journal of Clinical Endocrinology & Metabolism, 2010
- Elevated Levels of Insulin-Like Growth Factor (IGF)-I in Serum Rescue the Severe Growth Retardation of IGF-I Null MiceEndocrinology, 2009
- Growth Hormone, Insulin-Like Growth Factors, and the SkeletonEndocrine Reviews, 2008
- Conditional Deletion of Insulin-Like Growth Factor-I in Collagen Type 1α2-Expressing Cells Results in Postnatal Lethality and a Dramatic Reduction in Bone AccretionEndocrinology, 2007
- Disruption of insulin-like growth factor-I expression in type IIαI collagen-expressing cells reduces bone length and width in micePhysiological Genomics, 2007
- Outcomes in a 2-phase randomized clinical trial of early class II treatmentAmerican Journal of Orthodontics and Dentofacial Orthopedics, 2004
- Local administration of IGF-I stimulates the growth of mandibular condyle in mature ratsJournal of Orthodontics, 2004
- The twin block technique A functional orthopedic appliance systemAmerican Journal of Orthodontics and Dentofacial Orthopedics, 1988